Result description
Throughout the SME Phase I project (DELOX – 837148), Delox fully developed a prototype (now on TRL 7) consisting of a device that releases hydrogen peroxide vapour and a cartridge enclosing the dryVHP formulation. This prototype is designed for decontamination of small chambers (up to 2 m3), such as CO2 incubators and biosafety cabinets. Further, Delox characterized a scaled-up setup to produce the dryVHP formulation. Two US provisional patent applications were filed, out of which one was converted into a regular non-provisional patent application in February 2020, and another will be converted by early summer 2020. After SME Phase I, Delox successfully concluded field tests: two at the Laboratory of Bromatology and Biological Defence belonging to the Military Academy Research Center of the Portuguese Army, and one with Decontamination Specialty Equipment, a bio-decontamination company based in Erie, Pennsylvania, USA. Having been tested in operational environment, Delox technology for chamber decontamination reached TRL 7.
Addressing target audiences and expressing needs
- Grants and Subsidies
- Loans
- Venture Capital
Delox is fundraising €1M from VCs and other private investors for maturing its technology up to TRL 8 (device for chamber bio-decontamination) and start commercialization in the USA (market entry). Considering COVID-19, Delox is pivoting the project to bio-decontamination of Personal Protective Equipment (PPE) which is critically lacking in every healthcare facility. For this purpose, we seek public grants of €1M, supporting R&D projects responding to the pandemic. Moreover, we seek manufacturing partners that could produce our devices and healthcare partners eager to implement this solution.
- Public or private funding institutions
- Other Actors who can help us fulfil our market potential
- Private Investors
R&D, Technology and Innovation aspects
Delox commissioned its final product for chamber bio-decontamination (to be piloted in compounding pharmacies). Simultaneously, we are working towards designing a chamber where our device could decontaminate PPE (like masks) – once decontaminated they can be safely reused. Additionally, we are developing a scaled-down version, specifically for fast PPE decontamination of a small number of PPE.
Result submitted to Horizon Results Platform by DELOX – INVESTIGACAO, PROCESSOS E EQUIPAMENTOS CIENTIFICOS, LDA
Please 
Get instant access to tailored funding opportunities that perfectly match your needs. This powerful feature is exclusively available to our premium members—helping you save time, stay ahead of the competition, and secure the right funding faster.
Curious about who’s viewing your listings? Unlock insights into your last 20 visitors and discover potential leads instantly! 